LIFE SCIENCES RESEARCH PARTNERS VZW;KATHOLIEKE UNIVERSITEIT LEUVEN
发明人:
Jean-Marie SAINT-REMY
申请号：
US16804288
公开号：
US20200270331A1
申请日:
2020.02.28
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from an allograft antigen and a redox motif such as C-(X)2-[CST] (SEQ ID NO: 18) or [CST]-(X)2-C(SEQ ID NO: 19) in the prevention and/or treatment of allograft rejection and in the manufacture of medicaments therefore.
